medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2023, Number 1

<< Back Next >>

Rev Med UAS 2023; 13 (1)

Knowledge about biosafety for the management of cytostatic drugs in the staff of a Specialized Center for Oncology Care

Renovato-Hernández CS, Lagunillas-Esparza B, Ávila-Silva RI, Gallegos-García V, Reyes-Laris P, Medina-de la CO

Language: Spanish
References: 27
Page: 5-14
PDF size: 242.30 Kb.


ABSTRACT

Aim. To evaluate the level of knowledge about biosafety in the handling of cytostatic drugs that the personnel of a Specialized Center for Oncological Care. Material and methods. Cross-sectional exploratory research, carried out in a private Oncology Care Center in the city of San Luis Potosí. A validated instrument was applied to 12 participants to assess the level of knowledge, descriptive and inferential statistics were performed in the SPSS V.21 program. Results. 66.6% of the participants were men, 58.0% had a bachelor's or postgraduate degree, 34.0% of the staff had been working at the center for ‹10 years, 100% knew that it was a cytostatic drug and 67. 0% had a medium level of knowledge about the proper management of cytostatic waste. Conclusions. Antineoplastics are considered highly toxic drugs, which can be dangerous not only for patients, but also for health personnel, especially those involved in treatment, storage, cleaning, patient transfer, and even personnel focused on administrative processes.


REFERENCES

  1. Sargidy AAW, Yahia A, Ahmad M, Abdalla M,Khalil SN, Alasary S, et al. Knowledge of safehandling, administration, and waste managementof chemotherapeutic drugs among oncologynurses working at Khartoum OncologyHospital, Sudan. PeerJ 2022;10:e14173.

  2. Boakye D, Günther K, Niedermaier T, Haug U,Ahrens W, Nagrani R. Associations betweencomorbidities and advanced stage diagnosisof lung, breast, colorectal, and prostate cancer:A systematic review and meta-analysis.Cancer Epidemiol 2021;75:102054.

  3. Medina-de la Cruz O, Escoto-Chávez SE,Gaytán-Hernández D, Villegas-Hinojosa E,Terán-Figuera Y, Gallegos-García V. Identificacióndel polimorfismo en la MMP-7-181A>Gen mujeres potosinas con neoplasia intraepitelialcervical. Inv Cienc UAA 2021;(82):33- 41.

  4. Anttila JV, Shubin M, Cairns J, Borse F, GuoQ, Mononen T, et al. Contrasting the impact ofcytotoxic and cytostatic drug therapies on tumourprogression. PLoS Comput Biol.2019;15(11):e1007493.

  5. Asefa S, Aga F, Dinegde NG, Demie TG.Knowledge and Practices on the Safe Handlingof Cytotoxic Drugs Among OncologyNurses Working at Tertiary Teaching Hospitalsin Addis Ababa, Ethiopia. Drug HealthcPatient Saf 2021;13:71-80.

  6. Gajski G, Ladeira C, Gerić M, Garaj-VrhovacV, Viegas S. Genotoxicity assessment of a selectedcytostatic drug mixture in human lymphocytes:A study based on concentrationsrelevant for occupational exposure. EnvironRes. 2018;161:26-34.

  7. Simegn W, Dagnew B, Dagne H. Knowledgeand associated factors towards cytotoxic drughandling among University of Gondar ComprehensiveSpecialized Hospital health professionals,institutional-based cross-sectionalstudy. Environ Health Prev Med 2020;25:11.

  8. Varela-Díaz V, Pérez-Villa. M. Medidas debioseguridad en la manipulación de medicamentoscitotóxicos y signos y síntomas de laexposición al riesgo en el personal de enfermería.Rev Salud Bosque 2020; 10 (1): 32-40.

  9. Ghasemi L, Yousefzadeh S, Rastkari N, NaddafiK, Shariati Far N, Nabizadeh R. Evaluatethe types and amount of genotoxic waste inTehran University of Medical Science’s hospitals.J Environ Health Sci Eng 2018;16(2):171-179.

  10. Capoor MR, Bhowmik KT. Cytotoxic DrugDispersal, Cytotoxic Safety, and CytotoxicWaste Management: Practices and ProposedIndia-specific Guidelines. Indian J Med PaediatrOncol Off 2017;38(2):190-197.

  11. El-Ebiary AA, Abuelfadl AA, Sarhan NI. Evaluationof genotoxicity induced by exposure toantineoplastic drugs in lymphocytes of oncologynurses and pharmacists. J Appl Toxicol2013; 33 (3): 196-201.

  12. Lancharro PM, Iglesias CA, González-BarcalaFJ, González JDM. Evidence of exposure tocytostatic drugs in healthcare staff: a review ofrecent literature. Farm Hosp 2016;40(6):604-621.

  13. Baniasadi S, Alehashem M, Yunesian M,Rastkari N. Biological Monitoring ofHealthcare Workers Exposed to AntineoplasticDrugs: Urinary Assessment of Cyclophosphamideand Ifosfamide. Iran J PharmRes IJPR 2018;17(4):1458-1464.

  14. Mamani-Arizapana SM. Conocimientos quetienen las enfermeras sobre los riesgos en lamanipulación de citostáticos, en el Servicio dePediatría del INEN - 2010. Facultad de MedicinaHumana. Universidad Nacional Mayor deSan Marcos. Lima. 2010.

  15. Simegn W, Dagnew B, Dagne H. Knowledgeand associated factors towards cytotoxic drughandling among University of Gondar ComprehensiveSpecialized Hospital health professionals,institutional-based cross-sectionalstudy. Environ Health Prev Med 2020; 25 (11):1-8.

  16. DOF. Norma Oficial Mexicana NOM-087-ECOL-SSA1-2022, Protección ambiental, saludambiental, residuos peligrosos biológicosinfecciosos, clasificación y especificacionesde manejo. Cassio Luiselli Fernández, México,Distrito Federal, 17-02-2003 [06-02-2023]. Disponible enhttps://www.cndh.org.mx/DocTR/2016/JUR/A70/01/JUR-20170331-NOR14.pdf

  17. Boughattas AB, Bouraoui S, Debbabi F, ElGhazel H, Saad A, Mrizak N. Genotoxic riskassessment of nurses handling antineoplasticdrugs. Ann Biol Clin (Paris) 2010;68(5):545-553.

  18. Pieri M, Castiglia L, Basilicata P, Sannolo N,Acampora A, Miraglia N. Biological monitoringof nurses exposed to doxorubicin and epirubicinby a validated liquid chromatography/fluorescencedetection method. Ann Occup Hyg2010;54(4):368-376.

  19. Bouraoui S, Brahem A, Tabka F, Mrizek N,Saad A, Elghezal H. Assessment of chromosomalaberrations, micronuclei and proliferationrate index in peripheral lymphocytes fromTunisian nurses handling cytotoxic drugs. EnvironToxicol Pharmacol 2011;31(1):250-257.

  20. Friese CR, McArdle C, Zhao T, Sun D, SpasojevicI, Polovich M, et al. Antineoplastic drugexposure in an ambulatory setting: a pilotstudy. Cancer Nurs 2015;38(2):111-117.

  21. Leso V, Sottani C, Santocono C, Russo F,Grignani E, Iavicoli I. Exposure to AntineoplasticDrugs in Occupational Settings: A SystematicReview of Biological Monitoring Data.Int J Environ Res Public Health 2022;19(6):3737.

  22. Rittidet C, Chaiear N. Attitude and relationshipwith chemotherapy of personality in a universityhospital in the Northeast region. SrinagarindMed J 2021;36(4):444-450.

  23. Ha Z, Sm S, Rm ES, Wm S. Knowledge, attitudesand practices of safe handling of cytotoxicdrugs among oncology nurses in tantauniversity hospitals. Egypt J Occup Med2019;43(1):75-92.

  24. Momeni M, Danaei M, Askarian M. How donurses manage their occupational exposure tocytotoxic drugs? A descriptive survey in chemotherapysettings, Shiraz, Iran. Int J Occup EnvironMed 2013;4(2):102-106.

  25. Walton AL, Kneipp S, Linnan L, et al. NursingAssistants’ Use of Personal Protective EquipmentRegarding Contact With Excreta ContaminatedWith Antineoplastic Drugs. OncolNurs Forum 2019;46(6):689-700.

  26. Alehashem M, Baniasadi S. Safe Handling ofAnti-Neoplastic Drugs in the University Hospitals:A Descriptive Survey Study Among OncologyNurses. Int J Cancer Manag 2018; 11(2): :e6482.

  27. Elshamy K, El-Hadidi M, El-Roby M, Fouda M.Health Hazards among Oncology Nurses Exposedto Chemotherapy Drugs. Afr J HaematolOncol 2010;1(3).




2020     |     www.medigraphic.com